Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.

Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.

Item
http://www.wikidata.org/entity/Q33979445
Effects of sulfamethizole and amdinocillin against Escherichia coli strains (with various susceptibilities) in an ascending urinary tract infection mouse modelPharmacodynamics of cefquinome in a neutropenic mouse thigh model of Staphylococcus aureus infectionPharmacodynamic assessment of ertapenem (MK-0826) against Streptococcus pneumoniae in a murine neutropenic thigh infection model.Insufficient β-lactam concentrations in the early phase of severe sepsis and septic shock.Optimization of meropenem minimum concentration/MIC ratio to suppress in vitro resistance of Pseudomonas aeruginosaPharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target.Recommended β-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapyPharmacodynamic assessment of gatifloxacin against Streptococcus pneumoniae.Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.Ceftazidime dosage regimen in intensive care unit patients: from a population pharmacokinetic approach to clinical practice via Monte Carlo simulationsPharmacokinetics of ABT-773, a new semi-synthetic ketolide in neutropenic lung-infected mice: a population approach.
P2860

Pharmacodynamic assessment of cefprozil against Streptococcus pneumoniae: implications for breakpoint determinations.

Item
http://www.wikidata.org/entity/Q33979445
description
2000 nî lūn-bûn
@nan
2000 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Pharmacodynamic assessment of ...... for breakpoint determinations.
@ast
Pharmacodynamic assessment of ...... for breakpoint determinations.
@en
type
label
Pharmacodynamic assessment of ...... for breakpoint determinations.
@ast
Pharmacodynamic assessment of ...... for breakpoint determinations.
@en
prefLabel
Pharmacodynamic assessment of ...... for breakpoint determinations.
@ast
Pharmacodynamic assessment of ...... for breakpoint determinations.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P932
P356
P1433
P1476
Pharmacodynamic assessment of ...... for breakpoint determinations.
@en
P2093
P2860
P304
P31
P356
10.1128/AAC.44.5.1291-1295.2000
P407
P433
P478
P577
P5875
P698
P932